Quest Diagnostics Other Non-Current Liabilities increased by 6.8% to $1.02B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.5%, from $917.00M to $1.02B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 2.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $792.00M | $801.00M | $792.00M | $742.00M | $728.00M | $787.00M | $812.00M | $809.00M | $901.00M | $874.00M | $876.00M | $817.00M | $811.00M | $891.00M | $938.00M | $917.00M | $890.00M | $982.00M | $957.00M | $1.02B |
| QoQ Change | — | +1.1% | -1.1% | -6.3% | -1.9% | +8.1% | +3.2% | -0.4% | +11.4% | -3.0% | +0.2% | -6.7% | -0.7% | +9.9% | +5.3% | -2.2% | -2.9% | +10.3% | -2.5% | +6.8% |
| YoY Change | — | — | — | — | -8.1% | -1.7% | +2.5% | +9.0% | +23.8% | +11.1% | +7.9% | +1.0% | -10.0% | +1.9% | +7.1% | +12.2% | +9.7% | +10.2% | +2.0% | +11.5% |